On the eve of the 18th DIVI 2018 in Leipzig, CytoSorbents invited to the 5th German-speaking CytoSorb user meeting. An excellent speaker panel presented in Leipzig new data and insights on the following topics …
Continue readingDidYouKnow: John Collins Warren
Terumo Cardiovascular Group and CytoSorbents Announce CytoSorb Cardiac Surgery Partnership
“Our collaboration with CytoSorbents enables us to offer this innovative, easy-to-use blood purification therapy to address our customers’ most challenging cardiac cases,” stated Arik Anderson, President of Perfusion and Surgical Devices Division at Terumo. “CytoSorb integrates with the heart-lung machine platform, giving surgical teams, for the first time, the ability to safely reduce dangerous inflammatory mediators in real-time as they are being generated during cardiac surgery.”
Continue readingExtracorporeal cytokine adsorption using CytoSorb® filter for adjuvant therapy of septic shock
According to the current definition, sepsis is a life-threatening organ dysfunction due to a dysregulated body response to an infection. This systemic infection can be caused by bacteria, fungi or even viruses.
Continue readingCytoSorbents Highlights Survival Benefit of CytoSorb Therapy in Septic Shock
In this study, clinical researchers at Maasstad Hospital and at Erasmus University Medical Center in Rotterdam, Netherlands conducted a retrospective evaluation of 116 patients with septic shock, who required vasopressors to increase their blood pressure, and renal replacement therapy (RRT) due to kidney failure.
Continue reading